HIV-Associated Histoplasmosis: Current Perspectives

References

• McKinsey DS, Spiegel RA, Hutwagner L, et al. Prospective study of histoplasmosis in patients infected with human immunodeficiency virus: incidence, risk factors, and pathophysiology. Clin Infect Dis. 1997;24(6):1195–1203. doi:10.1086/cid.1997.24.issue-69195082
   PubMedGoogle Scholar
• Marukutira T, Huprikar S, Azie N, Quan SP, Meier-kriesche HU, Horn DL. Clinical characteristics and outcomes in 303 HIV-infected patients with invasive fungal infections: data from the Prospective Antifungal Therapy Alliance registry, a multicenter, observational study. HIV/AIDS (Auckland, N.z.). 2014;6:39–47. doi:10.2147/HIV.S53910
   PubMedGoogle Scholar
• Zerbe CS, Holland SM. Disseminated histoplasmosis in persons with interferon-gamma receptor 1 deficiency. Clin Infect Dis. 2005;41(4):e38–e41. doi:10.1086/43212016028145
   PubMed Web of Science ®Google Scholar
• Wheat LJ, Slama TG, Norton JA, et al. Risk factors for disseminated or fatal histoplasmosis. Analysis of a large urban outbreak. Ann Intern Med. 1982;96(2):159–163. doi:10.7326/0003-4819-96-2-1597059062
   PubMedGoogle Scholar
• Smith JA, Kauffman CA. Endemic fungal infections in patients receiving tumour necrosis factor-alpha inhibitor therapy. Drugs. 2009;69(11):1403–1415. doi:10.2165/00003495-200969110-0000219634920
   PubMed Web of Science ®Google Scholar
• Cuellar-rodriguez J, Avery RK, Lard M, et al. Histoplasmosis in solid organ transplant recipients: 10 years of experience at a large transplant center in an endemic area. Clin Infect Dis. 2009;49(5):710–716. doi:10.1086/60471219635026
   PubMedGoogle Scholar
• Odio CM, Navarrete M, Carrillo JM, Mora L, Carranza A. Disseminated histoplasmosis in infants. Pediatr Infect Dis J. 1999;18(12):1065–1068. doi:10.1097/00006454-199912000-0000710608625
   PubMedGoogle Scholar
• Randhawa HS. Occurrence of histoplasmosis in Asia. Mycopathol Mycol Appl. 1970;41(1):75–89. doi:10.1007/BF020514854938836
   PubMedGoogle Scholar
• Baker J, Setianingrum F, Wahyuningsih R, Denning DW. Mapping histoplasmosis in South East Asia - implications for diagnosis in AIDS. Emerg Microbes Infect. 2019;8(1):1139–1145. doi:10.1080/22221751.2019.164453931364950
   PubMed Web of Science ®Google Scholar
• Oladele RO, Toriello C, Ogunsola FT, et al. Prior subclinical histoplasmosis revealed in Nigeria using histoplasmin skin testing. PLoS One. 2018;13(5):e0196224. doi:10.1371/journal.pone.019622429742119
   PubMedGoogle Scholar
• Peigne V, Dromer F, Elie C, Lidove O, Lortholary O. Imported acquired immunodeficiency syndrome-related histoplasmosis in metropolitan France: a comparison of pre-highly active anti-retroviral therapy and highly active anti-retroviral therapy eras. Am J Trop Med Hyg. 2011;85(5):934–941. doi:10.4269/ajtmh.2011.11-022422049053
   PubMedGoogle Scholar
• Chu JH, Feudtner C, Heydon K, Walsh TJ, Zaoutis TE. Hospitalizations for endemic mycoses: a population-based national study. Clin Infect Dis. 2006;42(6):822–825. doi:10.1086/50040516477560
   PubMed Web of Science ®Google Scholar
• Loulergue P, Bastides F, Baudouin V, et al. Literature review and case histories of Histoplasma capsulatum var. duboisii infections in HIV-infected patients. Emerg Infect Dis. 2007;13(11):1647–1652. doi:10.3201/eid1311.07066518217546
   PubMedGoogle Scholar
• Darre T, Saka B, Mouhari-toure A, et al. Histoplasmosis by Histoplasma capsulatum var. duboisii Observed at the Laboratory of Pathological Anatomy of Lome in Togo. J Pathog. 2017;2017:2323412. doi:10.1155/2017/232341228804654
   PubMedGoogle Scholar
• Bongomin F, Gago S, Oladele RO, Denning DW. Global and Multi-National prevalence of fungal diseases-estimate precision. J Fungi (Basel). 2017;3(4):57.
   PubMedGoogle Scholar
• Adenis AA, Valdes A, Cropet C, et al. Burden of HIV-associated histoplasmosis compared with tuberculosis in Latin America: a modelling study. Lancet Infect Dis. 2018;18(10):1150–1159. doi:10.1016/S1473-3099(18)30354-230146320
   PubMed Web of Science ®Google Scholar
• Nacher M, Adenis A, Adriouch L, et al. What is AIDS in the Amazon and the Guianas? Establishing the burden of disseminated histoplasmosis. Am J Trop Med Hyg. 2011;84(2):239–240. doi:10.4269/ajtmh.2011.10-025121292891
   PubMedGoogle Scholar
• Oladele RO, Ayanlowo OO, Richardson MD, Denning DW. Histoplasmosis in Africa: an emerging or a neglected disease? PLoS Negl Trop Dis. 2018;12(1):e0006046. doi:10.1371/journal.pntd.000604629346384
   PubMed Web of Science ®Google Scholar
• Jones PG, Cohen RL, Batts DH, Silva J Jr. Disseminated histoplasmosis, invasive pulmonary aspergillosis, and other opportunistic infections in a homosexual patient with acquired immune deficiency syndrome. Sex Transm Dis. 1983;10(4):202–204. doi:10.1097/00007435-198311000-000106665665
   PubMedGoogle Scholar
• Wheat LJ, Connolly-stringfield PA, Baker RL, et al. Disseminated histoplasmosis in the acquired immune deficiency syndrome: clinical findings, diagnosis and treatment, and review of the literature. Medicine (Baltimore). 1990;69(6):361–374. doi:10.1097/00005792-199011000-000042233233
   PubMed Web of Science ®Google Scholar
• Hajjeh RA, Pappas PG, Henderson H, et al. Multicenter case-control study of risk factors for histoplasmosis in human immunodeficiency virus-infected persons. Clin Infect Dis. 2001;32(8):1215–1220. doi:10.1086/31975611283812
   PubMedGoogle Scholar
• Wheat LJ, Chetchotisakd P, Williams B, Connolly P, Shutt K, Hajjeh R. Factors associated with severe manifestations of histoplasmosis in AIDS. Clin Infect Dis. 2000;30(6):877–881. doi:10.1086/31382410854363
   PubMedGoogle Scholar
• Procknow JJ, Page MI, Loosli CG. Early pathogenesis of experimental histoplasmosis. Arch Pathol. 1960;69:413–426.14434993
   PubMedGoogle Scholar
• Newman SL. Macrophages in host defense against Histoplasma capsulatum. Trends Microbiol. 1999;7(2):67–71. doi:10.1016/S0966-842X(98)01431-010081083
   PubMedGoogle Scholar
• Woods JP, Heinecke EL, Luecke JW, et al. Pathogenesis of Histoplasma capsulatum. Semin Respir Infect. 2001;16(2):91–101. doi:10.1053/srin.2001.2423911521241
   PubMedGoogle Scholar
• Baughman RP, Kim CK, Vinegar A, Hendricks DE, Schmidt DJ, Bullock WE. The pathogenesis of experimental pulmonary histoplasmosis. Correlative studies of histopathology, bronchoalveolar lavage, and respiratory function. Am Rev Respir Dis. 1986;134(4):771–776. doi:10.1164/arrd.1986.134.4.7713767131
   PubMedGoogle Scholar
• Horwath MC, Fecher RA, Deepe GS Jr. Histoplasma capsulatum, lung infection and immunity. Future Microbiol. 2015;10(6):967–975. doi:10.2217/fmb.15.2526059620
   PubMedGoogle Scholar
• Deepe GS Jr. Modulation of infection with Histoplasma capsulatum by inhibition of tumor necrosis factor-alpha activity. Clin Infect Dis. 2005;41(Suppl 3):S204–S207. doi:10.1086/42999915983901
   PubMedGoogle Scholar
• Deepe GS Jr., Seder RA. Molecular and cellular determinants of immunity to Histoplasma capsulatum. Res Immunol. 1998;149(4–5):397–406; discussion 509–310. doi:10.1016/S0923-2494(98)80763-3
   PubMedGoogle Scholar
• Vanek J, Schwarz J. The gamut of histoplasmosis. Am J Med. 1971;50(1):89–104. doi:10.1016/0002-9343(71)90208-74924093
   PubMedGoogle Scholar
• Kauffman CA. Histoplasmosis: a clinical and laboratory update. Clin Microbiol Rev. 2007;20(1):115–132. doi:10.1128/CMR.00027-0617223625
   PubMed Web of Science ®Google Scholar
• Mandell W, Goldberg DM, Neu HC. Histoplasmosis in patients with the acquired immune deficiency syndrome. Am J Med. 1986;81(6):974–978. doi:10.1016/0002-9343(86)90390-63799657
   PubMedGoogle Scholar
• Edwards LB, Acquaviva FA, Livesay VT, Cross FW, Palmer CE. An atlas of sensitivity to tuberculin, PPD-B, and histoplasmin in the United States. Am Rev Respir Dis. 1969;99(4):1–132.4973586
   PubMedGoogle Scholar
• Benedict K, Thompson GR 3rd, Deresinski S, Chiller T. Mycotic infections acquired outside areas of known endemicity, United States. Emerg Infect Dis. 2015;21(11):1935–1941. doi:10.3201/eid2111.14195026485441
   PubMed Web of Science ®Google Scholar
• Vail GM, Young RS, Wheat LJ, Filo RS, Cornetta K, Goldman M. Incidence of histoplasmosis following allogeneic bone marrow transplant or solid organ transplant in a hyperendemic area. Transpl Infect Dis. 2002;4(3):148–151. doi:10.1034/j.1399-3062.2002.01016.x12421460
   PubMedGoogle Scholar
• Assi M, Martin S, Wheat LJ, et al. Histoplasmosis after solid organ transplant. Clin Infect Dis. 2013;57(11):1542–1549. doi:10.1093/cid/cit59324046304
   PubMedGoogle Scholar
• Straub M, Schwarz J. The healed primary complex in histoplasmosis. Am J Clin Pathol. 1955;25(7):727–741. doi:10.1093/ajcp/25.7.72714387973
   PubMedGoogle Scholar
• Mashburn JD, Dawson DF, Young JM. Pulmonary calcifications and histoplasmosis. Am Rev Respir Dis. 1961;84:208–216. doi:10.1164/arrd.1961.84.2.20813767747
   PubMedGoogle Scholar
• Hage CA, Wheat LJ, Loyd J, Allen SD, Blue D, Knox KS. Pulmonary histoplasmosis. Semin Respir Crit Care Med. 2008;29(2):151–165. doi:10.1055/s-2008-106385418365997
   PubMedGoogle Scholar
• Baddley JW, Sankara IR, Rodriquez JM, Pappas PG, Many WJ Jr. Histoplasmosis in HIV-infected patients in a southern regional medical center: poor prognosis in the era of highly active antiretroviral therapy. Diagn Microbiol Infect Dis. 2008;62(2):151–156. doi:10.1016/j.diagmicrobio.2008.05.00618597967
   PubMedGoogle Scholar
• Couppie P, Aznar C, Carme B, Nacher M. American histoplasmosis in developing countries with a special focus on patients with HIV: diagnosis, treatment, and prognosis. Curr Opin Infect Dis. 2006;19(5):443–449. doi:10.1097/01.qco.0000244049.15888.b916940867
   PubMedGoogle Scholar
• Karimi K, Wheat LJ, Connolly P, et al. Differences in histoplasmosis in patients with acquired immunodeficiency syndrome in the United States and Brazil. J Infect Dis. 2002;186(11):1655–1660. doi:10.1086/jid.2002.186.issue-1112447743
   PubMedGoogle Scholar
• Corcoran GR, Al-abdely H, Flanders CD, Geimer J, Patterson TF. Markedly elevated serum lactate dehydrogenase levels are a clue to the diagnosis of disseminated histoplasmosis in patients with AIDS. Clin Infect Dis. 1997;24(5):942–944. doi:10.1093/clinids/24.5.9429142797
   PubMedGoogle Scholar
• Kirn DH, Fredericks D, McCutchan JA, Stites D, Shuman M. Serum ferritin levels correlate with disease activity in patients with AIDS and disseminated histoplasmosis. Clin Infect Dis. 1995;21(4):1048–1049. doi:10.1093/clinids/21.4.10488645808
   PubMedGoogle Scholar
• Khasawneh FA, Ahmed S, Halloush RA. Progressive disseminated histoplasmosis presenting with cachexia and hypercalcemia. Int J Gen Med. 2013;6:79–83. doi:10.2147/IJGM.S4152023467543
   PubMedGoogle Scholar
• Assi MA, Sandid MS, Baddour LM, Roberts GD, Walker RC. Systemic histoplasmosis: a 15-year retrospective institutional review of 111 patients. Medicine (Baltimore). 2007;86(3):162–169. doi:10.1097/md.0b013e318067913017505255
   PubMed Web of Science ®Google Scholar
• Riddell J, Kauffman CA, Smith JA, et al. Histoplasma capsulatum endocarditis: multicenter case series with review of current diagnostic techniques and treatment. Medicine (Baltimore). 2014;93(5):186–193. doi:10.1097/MD.000000000000003425181311
   PubMedGoogle Scholar
• Wheat LJ, Batteiger BE, Sathapatayavongs B. Histoplasma capsulatum infections of the central nervous system. A clinical review. Medicine (Baltimore). 1990;69(4):244–260. doi:10.1097/00005792-199007000-000062197524
   PubMedGoogle Scholar
• Conces DJ Jr., Stockberger SM, Tarver RD, Wheat LJ. Disseminated histoplasmosis in AIDS: findings on chest radiographs. AJR Am J Roentgenol. 1993;160(1):15–19. doi:10.2214/ajr.160.1.84166148416614
   PubMedGoogle Scholar
• Chan KS, Looi LM, Chan SP. Disseminated histoplasmosis mimicking miliary tuberculosis: a case report. Malays J Pathol. 1993;15(2):155–158.8065179
   PubMedGoogle Scholar
• Agudelo CA, Restrepo CA, Molina DA, et al. Tuberculosis and histoplasmosis co-infection in AIDS patients. Am J Trop Med Hyg. 2012;87(6):1094–1098. doi:10.4269/ajtmh.2012.12-029223128292
   PubMed Web of Science ®Google Scholar
• Carreto-binaghi LE, Morales-villarreal FR, Garcia-de la Torre G, et al. Histoplasma capsulatum and Pneumocystis jirovecii coinfection in hospitalized HIV and non-HIV patients from a tertiary care hospital in Mexico. Int J Infect Dis. 2019;86:65–72. doi:10.1016/j.ijid.2019.06.01031207386
   PubMedGoogle Scholar
• Nunes JO, Pillon KR, Bizerra PL, Paniago AM, Mendes RP, Chang MR. The simultaneous occurrence of histoplasmosis and cryptococcal fungemia: a case report and review of the literature. Mycopathologia. 2016;181(11–12):891–897. doi:10.1007/s11046-016-0036-127423433
   PubMedGoogle Scholar
• Caceres DH, Tobon AM, Restrepo A, Chiller T, Gomez BL. The important role of co-infections in patients with AIDS and progressive disseminated histoplasmosis (PDH): A cohort from Colombia. Med Mycol Case Rep. 2018;19:41–44. doi:10.1016/j.mmcr.2017.07.00429379705
   PubMedGoogle Scholar
• Huber F, Nacher M, Aznar C, et al. AIDS-related Histoplasma capsulatum var. capsulatum infection: 25 years experience of French Guiana. AIDS. 2008;22(9):1047–1053. doi:10.1097/QAD.0b013e3282ffde6718520348
   PubMedGoogle Scholar
• Adenis A, Nacher M, Hanf M, et al. HIV-associated histoplasmosis early mortality and incidence trends: from neglect to priority. PLoS Negl Trop Dis. 2014;8(8):e3100. doi:10.1371/journal.pntd.000310025144374
   PubMedGoogle Scholar
• Hage CA, Ribes JA, Wengenack NL, et al. A multicenter evaluation of tests for diagnosis of histoplasmosis. Clin Infect Dis. 2011;53(5):448–454. doi:10.1093/cid/cir43521810734
   PubMed Web of Science ®Google Scholar
• Myint T, Anderson AM, Sanchez A, et al. Histoplasmosis in patients with human immunodeficiency virus/acquired immunodeficiency syndrome (HIV/AIDS): multicenter study of outcomes and factors associated with relapse. Medicine (Baltimore). 2014;93(1):11–18. doi:10.1097/MD.000000000000001624378739
   PubMedGoogle Scholar
• Johnson PC, Wheat LJ, Cloud GA, et al. Safety and efficacy of liposomal amphotericin B compared with conventional amphotericin B for induction therapy of histoplasmosis in patients with AIDS. Ann Intern Med. 2002;137(2):105–109. doi:10.7326/0003-4819-137-2-200207160-0000812118965
   PubMed Web of Science ®Google Scholar
• Caceres DH, Knuth M, Derado G, Lindsley MD. Diagnosis of progressive disseminated histoplasmosis in advanced HIV: a meta-analysis of assay analytical performance. J Fungi (Basel). 2019;5(3):76.
   PubMedGoogle Scholar
• Wheat LJ, Kohler RB, Tewari RP. Diagnosis of disseminated histoplasmosis by detection of Histoplasma capsulatum antigen in serum and urine specimens. N Engl J Med. 1986;314(2):83–88. doi:10.1056/NEJM1986010931402053941695
   PubMed Web of Science ®Google Scholar
• Durkin MM, Connolly PA, Wheat LJ. Comparison of radioimmunoassay and enzyme-linked immunoassay methods for detection of Histoplasma capsulatum var. capsulatum antigen. J Clin Microbiol. 1997;35(9):2252–2255. doi:10.1128/JCM.35.9.2252-2255.19979276396
   PubMedGoogle Scholar
• Swartzentruber S, LeMonte A, Witt J, et al. Improved detection of Histoplasma antigenemia following dissociation of immune complexes. Clin Vaccine Immunol. 2009;16(3):320–322. doi:10.1128/CVI.00409-0819144790
   PubMedGoogle Scholar
• Connolly PA, Durkin MM, Lemonte AM, Hackett EJ, Wheat LJ. Detection of histoplasma antigen by a quantitative enzyme immunoassay. Clin Vaccine Immunol. 2007;14(12):1587–1591. doi:10.1128/CVI.00071-0717913863
   PubMedGoogle Scholar
• Hage CA, Davis TE, Fuller D, et al. Diagnosis of histoplasmosis by antigen detection in BAL fluid. Chest. 2010;137(3):623–628. doi:10.1378/chest.09-170219837826
   PubMed Web of Science ®Google Scholar
• Bloch KC, Myint T, Raymond-guillen L, et al. Improvement in diagnosis of histoplasma meningitis by combined testing for histoplasma antigen and immunoglobulin G and immunoglobulin M anti-histoplasma antibody in cerebrospinal fluid. Clin Infect Dis. 2018;66(1):89–94. doi:10.1093/cid/cix70629020213
   PubMedGoogle Scholar
• Azuma I, Kanetsuna F, Tanaka Y, Yamamura Y, Carbonell LM. Chemical and immunological properties of galactomannans obtained from Histoplasma duboisii, Histoplasma capsulatum, Paracoccidioides brasiliensis and Blasomyces dermatitidis. Mycopathol Mycol Appl. 1974;54(1):111–125. doi:10.1007/BF020559794279334
   PubMedGoogle Scholar
• Durkin M, Connolly P, Kuberski T, et al. Diagnosis of coccidioidomycosis with use of the Coccidioides antigen enzyme immunoassay. Clin Infect Dis. 2008;47(8):e69–e73. doi:10.1086/59329918781884
   PubMed Web of Science ®Google Scholar
• Durkin M, Estok L, Hospenthal D, et al. Detection of Coccidioides antigenemia following dissociation of immune complexes. Clin Vaccine Immunol. 2009;16(10):1453–1456. doi:10.1128/CVI.00227-0919675225
   PubMedGoogle Scholar
• Bahr NC, Sarosi GA, Meya DB, et al. Seroprevalence of histoplasmosis in Kampala, Uganda. Med Mycol. 2016;54(3):295–300. doi:10.1093/mmy/myv08126527637
   PubMed Web of Science ®Google Scholar
• Theel ES, Jespersen DJ, Harring J, Mandrekar J, Binnicker MJ. Evaluation of an enzyme immunoassay for detection of Histoplasma capsulatum antigen from urine specimens. J Clin Microbiol. 2013;51(11):3555–3559. doi:10.1128/JCM.01868-1323966508
   PubMedGoogle Scholar
• Zhang C, Lei GS, Lee CH, Hage CA. Evaluation of two new enzyme immunoassay reagents for diagnosis of histoplasmosis in a cohort of clinically characterized patients. Med Mycol. 2015;53(8):868–873. doi:10.1093/mmy/myv06226337088
   PubMedGoogle Scholar
• Gutierrez ME, Canton A, Connolly P, Zarnowski R, Wheat LJ. Detection of Histoplasma capsulatum antigen in Panamanian patients with disseminated histoplasmosis and AIDS. Clin Vaccine Immunol. 2008;15(4):681–683. doi:10.1128/CVI.00358-0718287576
   PubMedGoogle Scholar
• Caceres DH, Samayoa BE, Medina NG, et al. Multicenter validation of commercial antigenuria reagents to diagnose progressive disseminated histoplasmosis in people living with HIV/AIDS in two Latin American countries. J Clin Microbiol. 2018;56:6. doi:10.1128/JCM.01959-17
   Google Scholar
• Falci DR, Monteiro AA, Braz Caurio CF, et al. Histoplasmosis, an underdiagnosed disease affecting people living with HIV/AIDS in Brazil: results of a Multicenter Prospective Cohort Study Using both classical mycology tests and histoplasma urine antigen detection. Open Forum Infect Dis. 2019;6(4):ofz073. doi:10.1093/ofid/ofz07330997365
   PubMedGoogle Scholar
• Hage CA, Kirsch EJ, Stump TE, et al. Histoplasma antigen clearance during treatment of histoplasmosis in patients with AIDS determined by a quantitative antigen enzyme immunoassay. Clin Vaccine Immunol. 2011;18(4):661–666. doi:10.1128/CVI.00389-1021307278
   PubMedGoogle Scholar
• Caceres DH, Gomez BL, Tobon AM, Chiller TM, Lindsley MD. Evaluation of a Histoplasma antigen Lateral Flow Assay for the rapid diagnosis of progressive disseminated histoplasmosis in Colombian patients with AIDS. Mycoses. 2019.
   PubMedGoogle Scholar
• Wheat J, French ML, Kohler RB, et al. The diagnostic laboratory tests for histoplasmosis: analysis of experience in a large urban outbreak. Ann Intern Med. 1982;97(5):680–685. doi:10.7326/0003-4819-97-5-6806814316
   PubMedGoogle Scholar
• Richer SM, Smedema ML, Durkin MM, et al. Improved diagnosis of acute pulmonary histoplasmosis by combining antigen and antibody detection. Clin Infect Dis. 2016;62(7):896–902. doi:10.1093/cid/ciw00726797210
   PubMed Web of Science ®Google Scholar
• Almeida MA, Damasceno LS, Pizzini CV, Muniz MM, Almeida-paes R, Zancope-oliveira RM. Role of Western blot assay for the diagnosis of histoplasmosis in AIDS patients from a National Institute of Infectious Diseases in Rio de Janeiro, Brazil. Mycoses. 2019;62(3):261–267. doi:10.1111/myc.1287730561870
   PubMed Web of Science ®Google Scholar
• Tang YW, Li H, Durkin MM, et al. Urine polymerase chain reaction is not as sensitive as urine antigen for the diagnosis of disseminated histoplasmosis. Diagn Microbiol Infect Dis. 2006;54(4):283–287. doi:10.1016/j.diagmicrobio.2005.10.00816466889
   PubMed Web of Science ®Google Scholar
• Azar MM, Hage CA. Laboratory diagnostics for histoplasmosis. J Clin Microbiol. 2017;55(6):1612–1620. doi:10.1128/JCM.02430-1628275076
   PubMed Web of Science ®Google Scholar
• Bongomin F, Kwizera R, Denning DW. Getting histoplasmosis on the map of international recommendations for patients with advanced HIV disease. J Fungi (Basel). 2019;5(3):80.
   PubMedGoogle Scholar
• Wheat J, Myint T, Guo Y, et al. Central nervous system histoplasmosis: multicenter retrospective study on clinical features, diagnostic approach and outcome of treatment. Medicine (Baltimore). 2018;97(13):e0245. doi:10.1097/MD.000000000001024529595679
   PubMedGoogle Scholar
• Myint T, Chow FC, Bloch KC, et al. Detection of (1,3)-beta-d-Glucan in Cerebrospinal Fluid in Histoplasma Meningitis. J Clin Microbiol. 2018;56:10. doi:10.1128/JCM.00663-18
   Google Scholar
• Wheat LJ, Freifeld AG, Kleiman MB, et al. Clinical practice guidelines for the management of patients with histoplasmosis: 2007 update by the Infectious Diseases Society of America. Clin Infect Dis. 2007;45(7):807–825. doi:10.1086/52125917806045
   PubMed Web of Science ®Google Scholar
• Reddy P, Gorelick DF, Brasher CA, Larsh H. Progressive disseminated histoplasmosis as seen in adults. Am J Med. 1970;48(5):629–636. doi:10.1016/0002-9343(70)90014-85425240
   PubMedGoogle Scholar
• Wheat J, Hafner R, Korzun AH, et al. Itraconazole treatment of disseminated histoplasmosis in patients with the acquired immunodeficiency syndrome. AIDS Clinical Trial Group. Am J Med. 1995;98(4):336–342. doi:10.1016/S0002-9343(99)80311-87709945
   PubMed Web of Science ®Google Scholar
• Wheat J, Hafner R, Wulfsohn M, et al. Prevention of relapse of histoplasmosis with itraconazole in patients with the acquired immunodeficiency syndrome. Ann Intern Med. 1993;118(8):610–616. doi:10.7326/0003-4819-118-8-199304150-000068383934
   PubMed Web of Science ®Google Scholar
• Ashbee HR, Barnes RA, Johnson EM, Richardson MD, Gorton R, Hope WW. Therapeutic drug monitoring (TDM) of antifungal agents: guidelines from the British Society for Medical Mycology. J Antimicrob Chemother. 2014;69(5):1162–1176. doi:10.1093/jac/dkt50824379304
   PubMed Web of Science ®Google Scholar
• Andes D, Pascual A, Marchetti O. Antifungal therapeutic drug monitoring: established and emerging indications. Antimicrob Agents Chemother. 2009;53(1):24–34. doi:10.1128/AAC.00705-0818955533
   PubMed Web of Science ®Google Scholar
• Lestner JM, Roberts SA, Moore CB, Howard SJ, Denning DW, Hope WW. Toxicodynamics of itraconazole: implications for therapeutic drug monitoring. Clin Infect Dis. 2009;49(6):928–930. doi:10.1086/60549919681707
   PubMed Web of Science ®Google Scholar
• Li RK, Ciblak MA, Nordoff N, Pasarell L, Warnock DW, McGinnis MR. In vitro activities of voriconazole, itraconazole, and amphotericin B against Blastomyces dermatitidis, Coccidioides immitis, and Histoplasma capsulatum. Antimicrob Agents Chemother. 2000;44(6):1734–1736. doi:10.1128/AAC.44.6.1734-1736.200010817743
   PubMed Web of Science ®Google Scholar
• Law D, Moore CB, Denning DW. Bioassay for serum itraconazole concentrations using hydroxyitraconazole standards. Antimicrob Agents Chemother. 1994;38(7):1561–1566. doi:10.1128/AAC.38.7.15617979289
   PubMed Web of Science ®Google Scholar
• Nivoix Y, Leveque D, Herbrecht R, Koffel JC, Beretz L, Ubeaud-sequier G. The enzymatic basis of drug-drug interactions with systemic triazole antifungals. Clin Pharmacokinet. 2008;47(12):779–792. doi:10.2165/0003088-200847120-0000319026034
   PubMed Web of Science ®Google Scholar
• Wheat LJ, Connolly P, Smedema M, et al. Activity of newer triazoles against Histoplasma capsulatum from patients with AIDS who failed fluconazole. J Antimicrob Chemother. 2006;57(6):1235–1239.16627592
   PubMed Web of Science ®Google Scholar
• Connolly P, Wheat LJ, Schnizlein-bick C, et al. Comparison of a new triazole, posaconazole, with itraconazole and amphotericin B for treatment of histoplasmosis following pulmonary challenge in immunocompromised mice. Antimicrob Agents Chemother. 2000;44(10):2604–2608. doi:10.1128/AAC.44.10.2604-2608.200010991831
   PubMedGoogle Scholar
• Restrepo A, Tobon A, Clark B, et al. Salvage treatment of histoplasmosis with posaconazole. J Infect. 2007;54(4):319–327. doi:10.1016/j.jinf.2006.05.00616824608
   PubMed Web of Science ®Google Scholar
• Wheat LJ, Connolly P, Smedema M, Brizendine E, Hafner R. Emergence of resistance to fluconazole as a cause of failure during treatment of histoplasmosis in patients with acquired immunodeficiency disease syndrome. Clin Infect Dis. 2001;33(11):1910–1913. doi:10.1086/cid.2001.33.issue-1111692303
   PubMedGoogle Scholar
• Wheat J, MaWhinney S, Hafner R, et al. Treatment of histoplasmosis with fluconazole in patients with acquired immunodeficiency syndrome. National Institute of Allergy and Infectious Diseases Acquired Immunodeficiency Syndrome Clinical Trials Group and Mycoses Study Group. Am J Med. 1997;103(3):223–232. doi:10.1016/S0002-9343(97)00151-49316555
   PubMedGoogle Scholar
• McKinsey DS, Kauffman CA, Pappas PG, et al. Fluconazole therapy for histoplasmosis. The National Institute of Allergy and Infectious Diseases Mycoses Study Group. Clin Infect Dis. 1996;23(5):996–1001. doi:10.1093/clinids/23.5.9968922792
   PubMedGoogle Scholar
• Spec A, Connolly P, Montejano R, Wheat LJ. In vitro activity of isavuconazole against fluconazole-resistant isolates of Histoplasma capsulatum. Med Mycol. 2018;56(7):834–837. doi:10.1093/mmy/myx13029253204
   PubMedGoogle Scholar
• Thompson GR 3rd, Rendon A, Ribeiro Dos Santos R, et al. Isavuconazole treatment of cryptococcosis and dimorphic mycoses. Clin Infect Dis. 2016;63(3):356–362. doi:10.1093/cid/ciw30527169478
   PubMed Web of Science ®Google Scholar
• Goldman M, Zackin R, Fichtenbaum CJ, et al. Safety of discontinuation of maintenance therapy for disseminated histoplasmosis after immunologic response to antiretroviral therapy. Clin Infect Dis. 2004;38(10):1485–1489. doi:10.1086/42074915156489
   PubMedGoogle Scholar
• Haynes RR, Connolly PA, Durkin MM, et al. Antifungal therapy for central nervous system histoplasmosis, using a newly developed intracranial model of infection. J Infect Dis. 2002;185(12):1830–1832. doi:10.1086/jid.2002.185.issue-1212085335
   PubMed Web of Science ®Google Scholar
• Wheat LJ, Cloud G, Johnson PC, et al. Clearance of fungal burden during treatment of disseminated histoplasmosis with liposomal amphotericin B versus itraconazole. Antimicrob Agents Chemother. 2001;45(8):2354–2357. doi:10.1128/AAC.45.8.2354-2357.200111451696
   PubMedGoogle Scholar
• Hage CA, Azar MM, Bahr N, Loyd J, Wheat LJ. Histoplasmosis: up-to-date evidence-based approach to diagnosis and management. Semin Respir Crit Care Med. 2015;36(5):729–745. doi:10.1055/s-0000007526398539
   PubMed Web of Science ®Google Scholar
• AIDS info, Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents with HIV. Available from: https://aidsinfo.nih.gov/contentfiles/lvguidelines/adult_oi.pdf. Accessed March 11, 2020.
   Google Scholar
• Shelburne SA 3rd, Darcourt J, White, AC Jr., et al. The role of immune reconstitution inflammatory syndrome in AIDS-related Cryptococcus neoformans disease in the era of highly active antiretroviral therapy. Clin Infect Dis. 2005;40(7):1049–1052. doi:10.1086/cid.2005.40.issue-715825000
   PubMed Web of Science ®Google Scholar
• Melzani A, De Reynal De Saint Michel R, Ntab B, et al. Incidence and trends in immune reconstitution inflammatory syndrome associated with Histoplasma capsulatum among people living with HIV: a 20-year case series and literature review. Clin Infect Dis. 2019. doi:10.1093/cid/ciz247
   Google Scholar
• Novak RM, Richardson JT, Buchacz K, et al. Immune reconstitution inflammatory syndrome: incidence and implications for mortality. AIDS. 2012;26(6):721–730. doi:10.1097/QAD.0b013e3283511e9122233655
   PubMed Web of Science ®Google Scholar
• Ratnam I, Chiu C, Kandala NB, Easterbrook PJ. Incidence and risk factors for immune reconstitution inflammatory syndrome in an ethnically diverse HIV type 1-infected cohort. Clin Infect Dis. 2006;42(3):418–427. doi:10.1086/49935616392092
   PubMed Web of Science ®Google Scholar
• Manabe YC, Campbell JD, Sydnor E, Moore RD. Immune reconstitution inflammatory syndrome: risk factors and treatment implications. J Acquir Immune Defic Syndr. 2007;46(4):456–462. doi:10.1097/QAI.0b013e3181594c8c18077835
   PubMed Web of Science ®Google Scholar
• Breton G, Duval X, Estellat C, et al. Determinants of immune reconstitution inflammatory syndrome in HIV type 1-infected patients with tuberculosis after initiation of antiretroviral therapy. Clin Infect Dis. 2004;39(11):1709–1712. doi:10.1086/cid.2004.39.issue-1115578375
   PubMed Web of Science ®Google Scholar
• Shelburne SA, Montes M, Hamill RJ. Immune reconstitution inflammatory syndrome: more answers, more questions. J Antimicrob Chemother. 2006;57(2):167–170. doi:10.1093/jac/dki44416354748
   PubMed Web of Science ®Google Scholar
• Meintjes G, Scriven J, Marais S. Management of the immune reconstitution inflammatory syndrome. Curr HIV/AIDS Rep. 2012;9(3):238–250. doi:10.1007/s11904-012-0129-522752438
   PubMedGoogle Scholar
• McKinsey DS, Wheat LJ, Cloud GA, et al. Itraconazole prophylaxis for fungal infections in patients with advanced human immunodeficiency virus infection: randomized, placebo-controlled, double-blind study. National Institute of Allergy and Infectious Diseases Mycoses Study Group. Clin Infect Dis. 1999;28(5):1049–1056. doi:10.1086/cid.1999.28.issue-510452633
   PubMed Web of Science ®Google Scholar